SOFIE services

Contract Manufacturing Services

In the development and manufacturing of theranostics and innovative technologies, timing and quality are imperative. Starting with a partner that provides a complete solution for pre-clinical through commercial supply will minimize the barriers to success. We provide a full range of Radiopharmaceutical Contract Manufacturing (RCM) services for diagnostic and therapeutic compounds from R&D, clinical trials, and commercial manufacturing stages. SOFIE relies on its proven expertise of developing, registering, and supplying radiopharmaceuticals under strict 21 CFR 211 and 212 CGMP standards to be the partner of choice for your new tracer or therapeutic.

Clinical Development Services

Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from University of Heidelberg, the team that invented PSMA-617 (Novartis). The FAPI family of compounds have demonstrated promising theranostic potential.